SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share (SGMO)

Q: What does CUSIP 800677106 represent in this 13F holders report?

CUSIP 800677106 is the security identifier for SGMO - SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share used to aggregate holder disclosures.

Q: How many institutions held SGMO - SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share in Q1 2026?

107 institutional investors reported SGMO - SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share for Q1 2026. Use the holders table for investor-level position and value details.

CUSIP: 800677106

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class: Equity / Common Stock, $0.01 par value per share
Shares outstanding: 414,359,662
Total 13F shares: 105,313,071
Share change: +41,284,659
Total reported value: $26,004,991
Put/Call ratio: 70%
Price per share: $0.25
Number of holders: 107
Value change: +$8,535,636
Number of buys: 51
Number of sells: 32

Quarterly Holders Quick Answers

What is CUSIP 800677106?
CUSIP 800677106 identifies SGMO - SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2025

Recent filing periods for CUSIP 800677106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SGMO - SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ARMISTICE CAPITAL, LLC	13D/G	—	9.8%	40,400,067	$10,504,017	$0	31 Mar 2026	13D/G
BIOGEN INC.	3/4/5	10%+ Owner	— class O/S missing	17,652,466	$6,745,007	—	26 Sep 2023	3/4/5
VANGUARD GROUP INC	13F	Company	2.9%	12,000,383	$5,040,161	—	31 Dec 2025	13F
WASATCH ADVISORS LP	13D/G 13F	Company	2.1%	6,188,358	$4,167,240	-$3,664,854	30 Sep 2025	13D/G 13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	2%	8,430,323	$3,540,736	—	31 Dec 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	1.1%	4,755,995	$1,997,518	—	31 Dec 2025	13F
BlackRock, Inc.	13F	Company	1.1%	4,571,786	$1,920,150	—	31 Dec 2025	13F
TWO SIGMA ADVISERS, LP	13F	Company	1%	4,343,255	$1,824,167	—	31 Dec 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.93%	3,866,026	$1,624,115	—	31 Dec 2025	13F
JANE STREET GROUP, LLC	13F	Company	0.7%	2,918,127	$1,225,614	—	31 Dec 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.52%	2,137,120	$897,590	—	31 Dec 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.41%	1,713,331	$719,599	—	31 Dec 2025	13F
STATE STREET CORP	13F	Company	0.33%	1,355,583	$569,345	—	31 Dec 2025	13F
Ikarian Capital, LLC	13F	Company	0.29%	1,218,671	$511,842	—	31 Dec 2025	13F
LUMINUS MANAGEMENT LLC	13F	Company	0.28%	1,158,761	$486,680	—	31 Dec 2025	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.25%	1,050,714	$441,300	—	31 Dec 2025	13F
ORACLE INVESTMENT MANAGEMENT INC	13F	Company	0.25%	1,035,742	$435,012	—	31 Dec 2025	13F
UBS Group AG	13F	Company	0.25%	1,024,475	$430,280	—	31 Dec 2025	13F
Invesco Ltd.	13F	Company	0.24%	1,000,292	$420,123	—	31 Dec 2025	13F
NORTHERN TRUST CORP	13F	Company	0.18%	737,867	$309,904	—	31 Dec 2025	13F
HighTower Advisors, LLC	13F	Company	0.17%	704,456	$295,872	—	31 Dec 2025	13F
Prathyusha Duraibabu	3/4/5	PRINCIPAL FINANCIAL OFFICER	— mixed-class rows	1,220,042 mixed-class rows	$263,026	—	22 Jan 2026	3/4/5
GROUP ONE TRADING LLC	13F	Company	0.12%	500,179	$210,075	—	31 Dec 2025	13F
MORGAN STANLEY	13F	Company	0.1%	423,752	$177,975	—	31 Dec 2025	13F
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.	13F	Company	0.1%	400,000	$168,000	—	31 Dec 2025	13F
Amy Pooler	3/4/5	VP, HEAD OF RESEARCH	— class O/S missing	193,923	$166,774	—	24 Aug 2024	3/4/5
Golden State Equity Partners	13F	Company	0.1%	395,943	$166,296	—	31 Dec 2025	13F
Diametric Capital, LP	13F	Company	0.1%	395,332	$166,039	—	31 Dec 2025	13F
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	13F	Company	0.08%	348,038	$146,176	—	31 Dec 2025	13F
Graham Capital Management, L.P.	13F	Company	0.08%	321,837	$135,172	—	31 Dec 2025	13F
Wealth Management Associates, Inc.	13F	Company	0.08%	315,800	$132,636	—	31 Dec 2025	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.07%	277,311	$116,471	—	31 Dec 2025	13F
FMR LLC	13F	Company	0.06%	265,408	$111,471	—	31 Dec 2025	13F
CANADA PENSION PLAN INVESTMENT BOARD	13F	Company	0.06%	251,900	$105,798	—	31 Dec 2025	13F
MERITAGE PORTFOLIO MANAGEMENT	13F	Company	0.05%	227,000	$95,340	—	31 Dec 2025	13F
David Mark McClung	3/4/5	EVP, Chief Operating Officer	— class O/S missing	212,471	$81,185	—	25 Nov 2023	3/4/5
GOLDMAN SACHS GROUP INC	13F	Company	0.05%	190,645	$80,071	—	31 Dec 2025	13F
XTX Topco Ltd	13F	Company	0.04%	183,531	$77,083	—	31 Dec 2025	13F
Cerity Partners LLC	13F	Company	0.04%	163,943	$68,856	—	31 Dec 2025	13F
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	0.04%	157,811	$66,280	—	31 Dec 2025	13F
Rolf Andrew Ramelmeier	3/4/5	EVP, Technical Operations	— class O/S missing	171,467	$65,518	—	25 May 2023	3/4/5
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	0.04%	150,000	$63,000	—	31 Dec 2025	13F
R Squared Ltd	13F	Company	0.04%	147,191	$61,820	—	31 Dec 2025	13F
Virtu Financial LLC	13F	Company	0.03%	132,356	$56,000	—	31 Dec 2025	13F
Hedges Asset Management LLC	13F	Company	0.03%	125,000	$52,500	—	31 Dec 2025	13F
Jason D. Fontenot	3/4/5	SVP, Chief Scientific Officer	— class O/S missing	136,270	$52,069	—	25 Nov 2023	3/4/5
PARKER H STEWART	3/4/5	Director	— mixed-class rows	162,600 mixed-class rows	$51,796	—	12 Jun 2025	3/4/5
Karen L. Smith	3/4/5	Director	— mixed-class rows	152,100 mixed-class rows	$46,966	—	12 Jun 2025	3/4/5
State of Wyoming	13F	Company	0.03%	111,527	$46,841	—	31 Dec 2025	13F
James R. Meyers	3/4/5	Director	— mixed-class rows	149,600 mixed-class rows	$45,816	—	12 Jun 2025	3/4/5

Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share (SGMO) as of Q1 2026

As of 31 Mar 2026, SANGAMO THERAPEUTICS, INC - Common Stock, $0.01 par value per share (SGMO) was held by 107 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 105,313,071 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, VANGUARD CAPITAL MANAGEMENT LLC, TWO SIGMA INVESTMENTS, LP, Balyasny Asset Management L.P., GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., RENAISSANCE TECHNOLOGIES LLC, UBS Group AG, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and VANGUARD FIDUCIARY TRUST CO. This page lists 107 institutional shareholders reporting positions in this security for the Q1 2026 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

104

Q1 2026 holders

107

Holder diff

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2026 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.